-
公开(公告)号：US20060234919A1
公开(公告)日：2006-10-19
申请号：US10488166
申请日：2002-09-02
IPC分类号： A61K38/22
CPC分类号： A61K38/095
摘要： The present invention relates to the use of substances with oxytocin for the preparation of pharmaceutical composition against inflamation. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against inflamation.
摘要翻译： 本发明涉及具有催产素的物质用于制备抗炎症药物组合物的用途。 它还涉及一种药物组合物，其包含至少一种具有抵抗炎症的催产素活性的物质。
-
2.发明授权公开(公告)号：US07727959B2
公开(公告)日：2010-06-01
申请号：US11345218
申请日：2006-02-02
IPC分类号： A61K38/11
CPC分类号： A61K38/11 , A61K2300/00
摘要： The present invention relates to the use of substances with oxytocin activity against climacteric disorders or similar symptoms due to dysfunction in the ovaries. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against climacteric disorders.
摘要翻译： 本发明涉及具有催产素活性的物质对由于卵巢功能障碍引起的更年期病症或类似症状的用途。 它还涉及包含至少一种具有催产素活性的物质与更年期病症的药物组合物。
-
3.发明授权公开(公告)号：US07405200B2
公开(公告)日：2008-07-29
申请号：US10469255
申请日：2002-02-28
摘要： A method of treating cancer in situ and cervicitis is disclosed. A pharmaceutical composition comprising at least one substance with oxytocin activity against cancer in situ and cervicitis and compound of the formula SEQ ID NO:2 is also disclosed.
摘要翻译： 公开了一种治疗原位癌和宫颈炎的方法。 还公开了一种药物组合物，其包含至少一种具有针对原位癌症和宫颈炎的催产素活性的物质和式SEQ ID NO：2的化合物。
-
4.发明授权Use of substances having oxytocin activity for preparation of medicaments for wound healing 有权使用具有催产素活性的物质制备用于伤口愈合的药物公开(公告)号：US06262021B1
公开(公告)日：2001-07-17
申请号：US09381799
申请日：1999-09-24
IPC分类号： A61K3811
CPC分类号： A61K38/11
摘要： Substances having oxytocin activity can be used for the preparation of a pharmaceutical composition for the curative or prophylactic treatment of wounds, such as chronic wounds. The wound healing effect can be strengthened or prolonged by combining oxytocin with estrogen.
摘要翻译： 具有催产素活性的物质可用于制备用于治疗或预防性治疗诸如慢性伤口的伤口的药物组合物。 通过将催产素与雌激素结合可以增强或延长伤口愈合效果。
-
公开(公告)号：US09034821B2
公开(公告)日：2015-05-19
申请号：US14111072
申请日：2012-04-13
摘要： The present invention relates to a novel pharmaceutical composition comprising oxytocin and/or one or more fragment(s) and/or variant(s) thereof and at least one non-ionic cellulose ether, such as hydroxypropylmethylcellulose, said pharmaceutical composition having a low pH. The present pharmaceutical composition has been shown to provide an exceptionally suitable environment for oxytocin, as the stability thereof has increased significantly as compared to previous compositions with this molecule. The pharmaceutical composition according to the invention can be used for medical purposes, such as in the treatment of climacteric disorders.
摘要翻译： 本发明涉及包含催产素和/或其一个或多个片段和/或其变体和至少一种非离子纤维素醚（例如羟丙基甲基纤维素）的新型药物组合物，所述药物组合物具有低pH 。 已经显示出本发明的药物组合物为催产素提供了非常合适的环境，因为与先前使用该分子的组合物相比，其稳定性显着增加。 根据本发明的药物组合物可用于医疗目的，例如治疗更年期疾病。
-
-
-
-
搜索结果
5 条记录 (耗时 0.02 秒)
